Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
Top Cited Papers
- 31 July 2011
- journal article
- Published by Springer Science and Business Media LLC in Nature Immunology
- Vol. 12 (9), 870-878
- https://doi.org/10.1038/ni.2077
Abstract
Regulation of tryptophan metabolism by indoleamine 2,3-dioxygenase (IDO) in dendritic cells (DCs) is a highly versatile modulator of immunity. In inflammation, interferon-γ is the main inducer of IDO for the prevention of hyperinflammatory responses, yet IDO is also responsible for self-tolerance effects in the longer term. Here we show that treatment of mouse plasmacytoid DCs (pDCs) with transforming growth factor-β (TGF-β) conferred regulatory effects on IDO that were mechanistically separable from its enzymic activity. We found that IDO was involved in intracellular signaling events responsible for the self-amplification and maintenance of a stably regulatory phenotype in pDCs. Thus, IDO has a tonic, nonenzymic function that contributes to TGF-β-driven tolerance in noninflammatory contexts. Download referencesKeywords
This publication has 53 references indexed in Scilit:
- An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T CellsThe Journal of Immunology, 2010
- MHC class II–restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell–mediated autoimmunityThe Journal of Experimental Medicine, 2010
- Dendritic Cells, Indoleamine 2,3 Dioxygenase and Acquired Immune PrivilegeInternational Reviews of Immunology, 2010
- Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and toleranceImmunological Reviews, 2010
- Origin and evolution of the adaptive immune system: genetic events and selective pressuresNature Reviews Genetics, 2009
- A-MADMAN: Annotation-based microarray data meta-analysis toolBMC Bioinformatics, 2009
- Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathwayThe International Journal of Biochemistry & Cell Biology, 2009
- SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesisProceedings of the National Academy of Sciences of the United States of America, 2008
- SOCS3 Targets Siglec 7 for Proteasomal Degradation and Blocks Siglec 7-mediated ResponsesPublished by Elsevier BV ,2007
- Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenaseProceedings of the National Academy of Sciences of the United States of America, 2007